Company intelligence / Profile preview

SP Nutraceuticals

Burlington, Ontario, Canadaprnewswire.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

SP Nutraceuticals has commercialized its flagship product Metavo, which contains the proprietary plant-derived bioactive AvoB (Avocatin B) from avocados. The company’s products are supported by over 10 years of clinical research and are available globally. Clinical studies have shown that AvoB can restore mitochondrial function and improve metabolic health markers such as insulin sensitivity and glucose tolerance[1][6][8].

Therapeutic areas: Metabolic Disorders
Modalities: Plant-based bioactive compoundSmall molecule (AvoB/Avocatin B)
Industry: Food & Nutrition

Drug pipeline

1 asset

avocatin B

Commercial

Indications: Metabolic disorders, Insulin resistance, Acute myeloid leukemia

Partnerships

ChopraX Ventures

Beyond the preview

Go deeper on SP Nutraceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SP Nutraceuticals.

Explore the full profile